Alpha Tau Medical insider sale of 37,500 shares

Alpha Tau Medical Ltd. reported insider sales under a Form 144: two dispositions of ordinary shares totaling 37,500 shares in June 2026.

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. reported insider sales under a Form 144: two dispositions of ordinary shares totaling 37,500 shares in June 2026. The filing also records 65,750 shares issued on 04/01/2023 upon RSU vesting.

Insights

Securities Attorney

Form 144 disclosures document reported insider dispositions and prior RSU issuance.

The filing lists two separate sales: 17,500 shares on 06/23/2026 for $167,051.00 and 20,000 shares on 06/25/2026 for $220,004.00. It also documents 65,750 shares issued upon RSU vesting on 04/01/2023.

These entries are routine compliance disclosures under transfer rules; cash‑flow treatment and any Rule 10b5‑1 plan references are not present in the excerpt.

Equity Analyst

Transactions are small absolute insider disposals by count and documented as Form 144 sales.

The two June 2026 dispositions sum to 37,500 shares, with proceeds of $167,051.00 and $220,004.00 respectively. The RSU issuance of 65,750 shares is a prior compensation event dated 04/01/2023.

Without additional context on total holdings or proportion of outstanding shares, the investor impact cannot be assessed from this excerpt.

Key Figures

June 23 sale: 17,500 shares June 25 sale: 20,000 shares Total June dispositions: 37,500 shares +3 more

6 metrics

June 23 sale 17,500 shares <date>06/23/2026</date> for <money>$167,051.00</money>

June 25 sale 20,000 shares <date>06/25/2026</date> for <money>$220,004.00</money>

Total June dispositions 37,500 shares Aggregate of two sales in <date>June 2026</date>

RSUs vested 65,750 shares Issued upon RSU vesting on <date>04/01/2023</date>

Proceeds (06/23/2026) <money>$167,051.00</money> Consideration reported for 17,500 shares

Proceeds (06/25/2026) <money>$220,004.00</money> Consideration reported for 20,000 shares

Key Terms

Form 144, RSUs, Ordinary Shares

3 terms

Form 144 regulatory

"Two dispositions listed with dates and proceeds (e.g., 06/23/2026 17,500 shares)."

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

RSUs financial

"Shares issued upon vesting of RSUs on 04/01/2023 (65,750 shares)."

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Ordinary Shares financial

"Multiple lines label the instrument as Ordinary Shares in the transactions section."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions does Alpha Tau Medical (DRTS) disclose in this Form 144?

The filing discloses two insider sales totaling 37,500 shares. It records 17,500 shares sold on 06/23/2026 for $167,051.00 and 20,000 shares sold on 06/25/2026 for $220,004.00. The document also notes a prior RSU issuance.

Does the filing show any shares issued to insiders as compensation?

Yes. The excerpt records 65,750 shares issued upon vesting of RSUs on 04/01/2023. The entry is labeled explicitly as shares issued upon RSU vesting and states no consideration was paid for those shares.

Who reported the sales and where are they located?

The sales are reported by Raphi Levy, with an address line shown as KIRYAT HAMADA 5 Jerusalem L3. The filing lists the two sale dates as 06/23/2026 and 06/25/2026 with the stated proceeds for each transaction.

Do the disclosed transactions indicate how proceeds were used or whether they were under a trading plan?

No. The provided excerpt lists sale amounts and dates but does not state the use of proceeds or reference any Rule 10b5‑1 trading plan. Cash‑flow treatment and plan attribution are not included in the visible text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/30/2026 - 11:34 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968095
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alpha Tau Medical Ltd.
SEC File Number	001-41316
Address of Issuer	KIRYAT HAMADA 5 JERUSALEM ISRAEL 9777605
Phone	972-3-577-4115
Name of Person for Whose Account the Securities are To Be Sold	Levy Raphi
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	20000	224400.00	88009737	06/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	04/01/2023	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			65750	04/01/2023	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Raphi Levy KIRYAT HAMADA 5 Jerusalem L3 9777605	Ordinary Shares	06/23/2026	17500	167051.00
Raphi Levy KIRYAT HAMADA 5 Jerusalem L3 9777605	Ordinary Shares	06/25/2026	20000	220004.00

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on March 24, 2026.
Date of Notice	06/30/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Raphael Levy By: /s/ Yohanan Azriel Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)